XSNX Share Price Performance
US$0.0001
-0.00 (-75.00%)
Price US$0.0001
Share Pricen/a
NovAccess Global Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
XSNX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
NovAccess Global Inc. Key Details
About XSNX
- Founded
- 1997
- Employees
- 2
- CEO
- WebsiteView website
NovAccess Global Inc., a biopharmaceutical company, engages in the development of novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in New York, New York.
